Neonatal Respiratory Diseases

Respiratory distress in the neonate most commonly presents as one or all of the following physical signs: tachypnea, grunting, nasal flaring, retractions, and cyanosis. A normal respiratory rate in a new-born is between 30 and 60 breaths/min; tachypnea is classified as respiratory rates greater than 60 breaths/min.

Neonatal respiratory distress syndrome (RDS) is a problem often seen in premature babies. The condition makes it hard for the baby to breathe. The disease is mainly caused by a lack of a slippery substance in the lungs called surfactant. This substance helps the lungs fill with air and keeps the air sacs from deflating. Surfactant is present when the lungs are fully developed.

Neonatal RDS can also be due to genetic problems with lung development. Most cases of RDS occur in babies born before 37 to 39 weeks. The more premature the baby is, the higher the chance of RDS after birth. The problem is uncommon in babies born full-term (after 39 weeks).

  • Chronic lung diseases
  • Bronchopulmonary dysplasia
  • Asthma in neonates
  • Pneumonia
  • Apnea
  • Persistent pulmonary hypertension of the newborn (PPHN)
  • Respiratory distress syndrome (RDS)


    Related Conference of Neonatal Respiratory Diseases

    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    August 27-28, 2025

    20th World Congress on Drug Formulation & Drug Delivery

    Amsterdam, Netherlands
    September 19-20, 2025

    18th World Drug Delivery Summit

    Paris, France
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 24-25, 2025

    5th World Congress on Rare Diseases & Orphan Drugs

    Aix-en-Provence, France
    October 23-24, 2025

    21st Annual Meet on Pharmaceutical Sciences

    Aix-en-Provence, France
    November 11-12, 2025

    6th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    November 13-14, 2025

    21st International Conference on Pharmaceutical Chemistry

    Aix-en-Provence, France
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Paris, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    December 01-02, 2025

    13th International Conference on Clinical Trials

    Vancouver, Canada
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, Aland Islands
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 21-22, 2026

    8th International Conference and Exhibition on Pain Management

    Aix-en-Provence, France

    Neonatal Respiratory Diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in